Table 3.
Effects of risk factors of MERS-CoV (n = 36)
| MERS-CoV Cases | Coefficient | Robust s.e. | t value | P > t | (95% Conf. Interval) | |
|---|---|---|---|---|---|---|
| Intercept | 0.400 | 0.434 | 0.920 | 0.365 | −0.049 | 1.292 |
| Camel exposure | 0.166 | 0.065 | 2.580 | 0.016a | 0.034 | 0.299 |
| Comorbidities | −0.114 | 0.099 | −1.140 | 0.264 | −0.318 | 0.091 |
| Healthcare worker | 0.004 | 0.070 | 0.060 | 0.951 | −0.140 | 0.148 |
| Saudi Arabia | 0.149 | 0.034 | 4.430 | <0.001a | 0.080 | 0.217 |
| Middle East | 0.511 | 0.134 | 3.810 | 0.001a | 0.235 | 0.788 |
| Male | 0.372 | 0.093 | 4.020 | <0.001a | 0.182 | 0.563 |
| Age 30–59 years | 0.596 | 0.094 | 6.350 | <0.001a | 0.403 | 0.789 |
| Age ⩾ 60 years | 0.493 | 0.164 | 3.010 | 0.006a | 0.156 | 0.831 |
| Exposure to MERS-CoV cases | 0.239 | 0.055 | 4.360 | <0.001a | 0.126 | 0.352 |
Significant at <5% level.